| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX010 (ip) | median survival time | saline | 2.5 mg/kg/injection | 155.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 5.0 mg/kg/injection | 140.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 5.0 mg/kg/injection | 135.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 10.0 mg/kg/injection | 140.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 10.0 mg/kg/injection | 200.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 20.0 mg/kg/injection | 116.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 20.0 mg/kg/injection | 235.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 252.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 270.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |